Stem Cells Companies Strategic Expansion Initiatives, Revenue Diversification, Strategic Joint Ventures, Licensing and Monetization

Stem Cells Manufacturers and Market Growth

The global stem cells market size was estimated at US$ 14.92 billion in 2023 and is projected to grow to US$ 49.26 billion by 2034, rising at a compound annual growth rate (CAGR) of 11.47% from 2023 to 2034.

Top Companies in the Stem Cells Market

• STEMCELL Technologies Inc.
• Mayo Clinic
• CellGenix GmbH
• Merck KGaA
• Takara Bio
• PromoCell GmbH
• Cellartis AB
• AcceGen
• ATCC
• Lonza
• Bio-Techne
• Cell Applications, Inc.
• Thermo Fisher Scientific, Inc.

Innovation by Mayo Clinic in the Stem Cells Market

Contribution by STEMCELL Technologies in the Stem Cells Market

Recent Developments in the Stem Cells Market

• In April 2024, future therapeutics and regenerative medicine can benefit from the mass production of pluripotent stem cells thanks to a novel paradigm. According to new research by experts at Northeastern University, artificial intelligence may be used to produce pluripotent stem cells on a massive scale. These cells might be used to cure diseases like cancer, Parkinson's disease, or Alzheimer's, as well as to repair spinal cords and slow down the aging process.
• In June 2023, bringing together scientists, legal academics, bioethics experts, and representatives from key funders and regulators of this research, Cambridge Reproduction is the project leader for Governance of Stem Cell-Based Embryo Models (G-SCBEM). Three-dimensional constructs that replicate certain elements of embryonic development are known as stem cell-based embryo models or SCBEMs. These crucial early developmental periods, which are often closed off to researchers, may be better understood with the help of SCBEMs.

Stem Cells and U.S. Medical Products Market Shipment Summary